Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04657159Completed

Health-economic Evaluation of Interventional Pain Management Compared to Pain Rehabilitation

Role: lead

NCT01836666Completed

Effects on Health Related Quality of Life Among Patients With Chronic Pain by Interventional Pain Management

Role: lead

NCT01835704Completed

Health-economic Evaulation of Interventional Pain Mangement

Role: lead

NCT01838603Completed

Patient Experience of Interventional Pain Management. Qualitative Study

Role: lead

All 4 trials loaded